{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:21:46Z","timestamp":1792657306588,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T00:00:00Z","timestamp":1455494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T00:00:00Z","timestamp":1455494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s11916-016-0548-x","type":"journal-article","created":{"date-parts":[[2016,2,15]],"date-time":"2016-02-15T03:39:44Z","timestamp":1455507584000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":152,"title":["Post-herpetic Neuralgia: a Review"],"prefix":"10.1007","volume":"20","author":[{"given":"Graham R.","family":"Hadley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Gayle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Ripoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Argoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel J.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,15]]},"reference":[{"issue":"3 suppl","key":"548_CR1","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1586\/erv.10.30","volume":"9","author":"RW Johnson","year":"2010","unstructured":"Johnson RW. Herpes zoster and postherpetic neuralgia. Expert Rev Vaccines. 2010;9(3 suppl):21\u20136.","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"548_CR2","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4065\/84.3.274","volume":"84","author":"P Sampathkumar","year":"2009","unstructured":"Sampathkumar P, Drage LA, Martin DP. Herpes zoster (shingles) and postherpetic neuralgia. Mayo Clin Proc. 2009;84(3):274\u201380.","journal-title":"Mayo Clin Proc"},{"key":"548_CR3","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMcp1403062","volume":"371","author":"RW Johnson","year":"2014","unstructured":"Johnson RW, Rice Andrew SC. Postherpetic Neuralgia. N Engl J Med. 2014;371:1526\u201333. doi:10.1056\/NEJMcp1403062. This manuscript exhibit a comprehensive review of the pathophysiology and current management of the subject at hand, postherpetic neuralgia.","journal-title":"N Engl J Med"},{"issue":"11","key":"548_CR4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1097\/INF.0b013e3181a90b16","volume":"28","author":"R Civen","year":"2009","unstructured":"Civen R, Chaves SS, Jumaan A, et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J. 2009;28(11):954\u20139.","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"548_CR5","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","volume":"20","author":"RF Itzler","year":"2005","unstructured":"Itzler RF, Insinga RP, Pellissier JM, Saddier P, Nikas AA. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med. 2005;20(8):748\u201353.","journal-title":"J Gen Intern Med"},{"issue":"2","key":"548_CR6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5070\/D35HF1G4M1","volume":"14","author":"M Ferreira","year":"2008","unstructured":"Ferreira M, Sanches M, Teixeira M, Guerra M, Selores M. Persistent varicella as the initial manifestation of systemic lymphoma. Dermatol Online J. 2008;14(2):24.","journal-title":"Dermatol Online J"},{"issue":"2","key":"548_CR7","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.athoracsur.2008.11.004","volume":"87","author":"L Fuks","year":"2009","unstructured":"Fuks L, Shitrit D, Fox BD, et al. Herpes zoster after lung trans- plantation: incidence, timing, and outcome. Ann Thorac Surg. 2009;87(2):423\u20136.","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"548_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.5021\/ad.2010.22.2.199","volume":"22","author":"BS Shin","year":"2010","unstructured":"Shin BS, Na CH, Song IG, Choi KC. A case of human immunodeficiency virus infection initially presented with disseminated herpes zoster. Ann Dermatol. 2010;22(2):199\u2013202.","journal-title":"Ann Dermatol"},{"key":"548_CR9","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1525-1497.2005.0150.x","volume":"20","author":"RP Insinga","year":"2005","unstructured":"Insinga RP, Itzler RF, Pellissier JM, Saddier P, Nikas AA. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med. 2005;20:748\u201353.","journal-title":"J Gen Intern Med"},{"key":"548_CR10","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.4065\/82.11.1341","volume":"82","author":"BP Yawn","year":"2007","unstructured":"Yawn BP, Saddier P, Wollan PC, St Sauver JL, Kurland MJ, Sy LS. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc. 2007;82:1341\u20139 [Erratum, Mayo Clin Proc 2008;83:255.].","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"548_CR11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jpainsymman.2004.01.014","volume":"28","author":"CE Argoff","year":"2004","unstructured":"Argoff CE, Katz N, Backonja M. Treatment of postherpetic neuralgia: a review of therapeutic options. J Pain Symptom Manag. 2004;28(4):396\u2013411.","journal-title":"J Pain Symptom Manag"},{"issue":"23\u201324","key":"548_CR12","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1016\/S0264-410X(01)00044-5","volume":"19","author":"WJ Edmunds","year":"2001","unstructured":"Edmunds WJ, Brisson M, Rose JD. The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine. 2001;19(23\u201324):3076\u201390.","journal-title":"Vaccine"},{"issue":"5","key":"548_CR13","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/00005792-198209000-00003","volume":"61","author":"MW Ragozzino","year":"1982","unstructured":"Ragozzino MW, Melton 3rd LJ, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore). 1982;61(5):310\u20136.","journal-title":"Medicine (Baltimore)"},{"key":"548_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0304-3959(96)03122-3","volume":"67","author":"RH Dworkin","year":"1996","unstructured":"Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain. 1996;67:241\u201351.","journal-title":"Pain"},{"key":"548_CR15","first-page":"661","volume-title":"Pain\u2014handbook of clinical neurology","author":"CPN Watson","year":"2006","unstructured":"Watson CPN, Oaklander AL. Postherpetic neuralgia. In: Cervero F, Jensen TS, editors. Pain\u2014handbook of clinical neurology, vol. 81. Edinburgh: Elsevier; 2006. p. 661\u201377."},{"key":"548_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0304-3959(01)00400-6","volume":"96","author":"AL Oaklander","year":"2002","unstructured":"Oaklander AL, Cohen SP, Raju SV. Intractable postherpetic itch and cutaneous deafferentation after facial shingles. Pain. 2002;96:9\u201312.","journal-title":"Pain"},{"key":"548_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S1526-5900(03)00637-0","volume":"4","author":"AL Oaklander","year":"2003","unstructured":"Oaklander AL, Bowsher D, Galer B, Haanpaa M, Jensen MP. Herpes zoster itch: preliminary epidemiologic data. J Pain. 2003;4:338\u201343.","journal-title":"J Pain"},{"key":"548_CR18","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.ejpain.2007.11.006","volume":"12","author":"HC Daniel","year":"2008","unstructured":"Daniel HC, Narewska J, Serpell M, Hoggart B, Johnson R, Rice AS. Comparison of psychological and physical function in neuropathic pain and nociceptive pain: implications for cognitive behavioral pain management programs. Eur J Pain. 2008;12:731\u201341. 14.","journal-title":"Eur J Pain"},{"key":"548_CR19","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/AJP.0b013e3181eef686","volume":"26","author":"M Drolet","year":"2010","unstructured":"Drolet M, Brisson M, Levin MJ, et al. A prospective study of the herpes zoster severity of illness. Clin J Pain. 2010;26:656\u201366.","journal-title":"Clin J Pain"},{"key":"548_CR20","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s40266-012-0014-3","volume":"29","author":"N Srinivas","year":"2012","unstructured":"Srinivas N, Patricia M-F. Diagnosing and managing postherpetic neuralgia. Drugs Aging. 2012;29:863\u20139.","journal-title":"Drugs Aging"},{"key":"548_CR21","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1093\/brain\/23.3.353","volume":"23","author":"H Head","year":"1900","unstructured":"Head H, Campbell A. The pathology of herpes zoster and its bearing on sensory localisation. Brain. 1900;23:353\u2013532.","journal-title":"Brain"},{"issue":"1","key":"548_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/00000542-200107000-00034","volume":"95","author":"CJ Woolf","year":"2001","unstructured":"Woolf CJ, Max MB. Mechanism-based pain diagnosis: issues for analgesic drug development. Anesthesiology. 2001;95(1):241\u20139.","journal-title":"Anesthesiology"},{"issue":"14","key":"548_CR23","doi-asserted-by":"publisher","first-page":"7723","DOI":"10.1073\/pnas.96.14.7723","volume":"96","author":"CJ Woolf","year":"1999","unstructured":"Woolf CJ, Costigan M. Transcriptional and posttranslational plasticity and the generation of inflammatory pain. Proc Natl Acad Sci U S A. 1999;96(14):7723\u201330.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"548_CR24","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","volume":"9","author":"R Baron","year":"2010","unstructured":"Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms and treatment. Lancet Neurol. 2010;9(8):807\u201319.","journal-title":"Lancet Neurol"},{"issue":"1\u20132","key":"548_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.pain.2005.08.003","volume":"118","author":"EM Garry","year":"2005","unstructured":"Garry EM, Delaney A, Anderson HA, et al. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitization that is attenuated by gabapentin or sodium channel blocking drugs. Pain. 2005;118(1\u20132):97\u2013111.","journal-title":"Pain"},{"key":"548_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0304-3959(91)90124-G","volume":"44","author":"CP Watson","year":"1991","unstructured":"Watson CP, Deck JH, Morshead C, Van der Kooy D, Evans RJ. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain. 1991;44:105\u201317.","journal-title":"Pain"},{"key":"548_CR27","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1212\/WNL.51.5.1405","volume":"51","author":"P Dastidar","year":"1998","unstructured":"Dastidar P, Haanp\u00e4\u00e4 M, Weinberg A, Levin M, Miettinen A, Lapinlampi A, et al. CSF and MRI findings in patients with acute herpes zoster. Neurology. 1998;51:1405\u201311.","journal-title":"Neurology"},{"key":"548_CR28","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/S1386-6532(10)70003-2","volume":"48","author":"W Opstelten","year":"2010","unstructured":"Opstelten W, McElhaney J, Weinberger B, Oaklander AL, Johnson R. The impact of varicella zoster virus: chronic pain. J Clin Virol. 2010;48:S8\u2013S13.","journal-title":"J Clin Virol"},{"key":"548_CR29","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/(SICI)1097-4598(199711)20:11<1433::AID-MUS11>3.0.CO;2-2","volume":"20","author":"M Haanp\u00e4\u00e4","year":"1997","unstructured":"Haanp\u00e4\u00e4 M, H\u00e4kkinen V, Nurmikko T. Motor involvement in acute herpes zoster. Muscle Nerve. 1997;20:1433\u20138.","journal-title":"Muscle Nerve"},{"issue":"1 Suppl 1","key":"548_CR30","first-page":"S10","volume":"9","author":"OA Louise","year":"2008","unstructured":"Louise OA. Mechanisms of pain and itch caused by herpes zoster (shingles). J Pain. 2008;9(1 Suppl 1):S10\u20138.","journal-title":"J Pain"},{"issue":"4","key":"548_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1006\/nbdi.1998.0204","volume":"5","author":"H Fields","year":"1998","unstructured":"Fields H, Rowbotham M, Baron R. Postherpetic neuralgia: irritable nociceptors and deafferentation. Neurobiol Dis. 1998;5(4):209\u201327.","journal-title":"Neurobiol Dis"},{"key":"548_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0304-3959(00)00481-4","volume":"92","author":"AL Oaklander","year":"2001","unstructured":"Oaklander AL. The density of remaining nerve endings in human skin with and without postherpetic neuralgia after shingles. Pain. 2001;92:139\u201345.","journal-title":"Pain"},{"issue":"1 suppl 1","key":"548_CR33","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.jpain.2007.10.008","volume":"9","author":"RH Dworkin","year":"2008","unstructured":"Dworkin RH, Gnann Jr JW, Oaklander A, Raja SN, Schmader KE, Whitley RJ. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain. 2008;9(1 suppl 1):S37\u201344.","journal-title":"J Pain"},{"issue":"3","key":"548_CR34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1001\/jama.287.3.337","volume":"287","author":"DW Kaufman","year":"2002","unstructured":"Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA. 2002;287(3):337\u201344.","journal-title":"JAMA"},{"issue":"4","key":"548_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3810\/pgm.2013.07.2690","volume":"125","author":"RN Harden","year":"2013","unstructured":"Harden RN, Kaye AD, Kintanar T, Argoff CE. Evidence-based guidance for the management of postherpetic neuralgia in primary care. Postgrad Med. 2013;125(4):191\u2013202. doi:10.3810\/pgm.2013.07.2690. This manuscript exhibit a comprehensive review of the pathophysiology and current management of the subject at hand, postherpetic neuralgia.","journal-title":"Postgrad Med"},{"issue":"5","key":"548_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2165\/11536540-000000000-00000","volume":"27","author":"H Smith","year":"2010","unstructured":"Smith H, Bruckenthal P. Implications of opioid analgesia for medically complicated patients. Drugs Aging. 2010;27(5):417\u201333. doi:10.2165\/11536540-000000000-00000. Review.","journal-title":"Drugs Aging"},{"issue":"3 Suppl","key":"548_CR37","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","volume":"85","author":"RH Dworkin","year":"2010","unstructured":"Dworkin RH, O'Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85(3 Suppl):S3\u201314. Review.","journal-title":"Mayo Clin Proc"},{"key":"548_CR38","doi-asserted-by":"crossref","unstructured":"American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. Pain Med. 2009;10(6):1062\u201383.","DOI":"10.1111\/j.1526-4637.2009.00699.x"},{"key":"548_CR39","doi-asserted-by":"crossref","unstructured":"Hadjistavropoulos T, Herr K, Turk DC, Fine PG, Dworkin RH, Helme R, Jackson K, Parmelee PA, Rudy TE, Lynn Beattie B, Chibnall JT, Craig KD, Ferrell B, Ferrell B, Fillingim RB, Gagliese L, Gallagher R, Gibson SJ, Harrison EL, Katz B, Keefe FJ, Lieber SJ, Lussier D, Schmader KE, Tait RC, Weiner DK, Williams J. AAN (American Academy of Neurology). 2011. Clinical Practice Guideline Process Manual, 2011 Ed. St. Paul, MN: The American Academy of Neurology Clin J Pain. 2007;23(1 Suppl):S1-43.","DOI":"10.1097\/AJP.0b013e31802be869"},{"issue":"suppl","key":"548_CR40","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.1002\/ana.410350715","volume":"35","author":"MB Max","year":"1994","unstructured":"Max MB. Treatment of post-herpetic neuralgia: antidepressants. Ann Neurol. 1994;35(suppl):S50\u20133.","journal-title":"Ann Neurol"},{"issue":"3","key":"548_CR41","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10865-007-9147-y","volume":"31","author":"KS Ingersoll","year":"2008","unstructured":"Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med. 2008;31(3):213\u201324.","journal-title":"J Behav Med"},{"key":"548_CR42","doi-asserted-by":"publisher","first-page":"469","DOI":"10.2147\/TCRM.S50212","volume":"9","author":"BM Thomas","year":"2013","unstructured":"Thomas BM, Farquhar-Smith P. Gabapentin enacarbil extended release for the treatment of postherpetic neuralgia in adults. Ther Clin Risk Manag. 2013;9:469\u201375. doi:10.2147\/TCRM.S50212.","journal-title":"Ther Clin Risk Manag"},{"key":"548_CR43","first-page":"17","volume":"4","author":"KA Cappuzzo","year":"2009","unstructured":"Cappuzzo KA. Treatment of postherpetic neuralgia: focus on pregabalin. Clin Interv Aging. 2009;4:17\u201323.","journal-title":"Clin Interv Aging"},{"key":"548_CR44","volume":"3","author":"RA Moore","year":"2009","unstructured":"Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009;3, CD007076. Review.","journal-title":"Cochrane Database Syst Rev."}],"updated-by":[{"DOI":"10.1007\/s11916-016-0566-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T00:00:00Z","timestamp":1458604800000}}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-016-0548-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-016-0548-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-016-0548-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-016-0548-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T17:43:55Z","timestamp":1692207835000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-016-0548-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,15]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["548"],"URL":"https:\/\/doi.org\/10.1007\/s11916-016-0548-x","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,15]]},"assertion":[{"value":"15 February 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Graham R. Hadley, Julie A. Gayle, Juan Ripoll, Mark R. Jones, Rachel J. Kaye, and Alan D. Kaye declare that they have no conflict of interest.Charles E. Argoff declares personal fees for consultant work for Pfizer, Depomed, and XenoPort and honoraria from Depomed and XenoPort.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"17"}}